Stress/cell death pathways, neuroinflammation, and neuropathic pain
L Li, T Li, X Qu, G Sun, Q Fu, G Han - Immunological reviews, 2024 - Wiley Online Library
Neuropathic pain is a common and debilitating modality of chronic pain induced by a lesion
or disease of the somatosensory nervous system. Albeit the elucidation of numerous …
or disease of the somatosensory nervous system. Albeit the elucidation of numerous …
Immunotherapies in chronic pain through modulation of neuroimmune interactions
It is generally believed that immune activation can elicit pain through production of
inflammatory mediators that can activate nociceptive sensory neurons. Emerging evidence …
inflammatory mediators that can activate nociceptive sensory neurons. Emerging evidence …
PD-L1/PD-1 pathway: a potential neuroimmune target for pain relief
D Deng, T Zhang, L Ma, W Zhao, S Huang, K Wang… - Cell & Bioscience, 2024 - Springer
Pain is a common symptom of many diseases with a high incidence rate. Clinically, drug
treatment, as the main method to relieve pain at present, is often accompanied by different …
treatment, as the main method to relieve pain at present, is often accompanied by different …
From pain to tumor immunity: influence of peripheral sensory neurons in cancer
U Mardelle, N Bretaud, C Daher, V Feuillet - Frontiers in Immunology, 2024 - frontiersin.org
The nervous and immune systems are the primary sensory interfaces of the body, allowing it
to recognize, process, and respond to various stimuli from both the external and internal …
to recognize, process, and respond to various stimuli from both the external and internal …
Sex differences in PD‐L1‐induced analgesia in paclitaxel‐induced peripheral neuropathy mice depend on TRPV1‐based inhibition of CGRP
Y Cao, W Jiang, F Yan, Y Pan, L Gei… - CNS Neuroscience …, 2024 - Wiley Online Library
Aims Paclitaxel (PTX) is extensively utilized in the management of diverse solid tumors,
frequently resulting in paclitaxel‐induced peripheral neuropathy (PIPN). The present study …
frequently resulting in paclitaxel‐induced peripheral neuropathy (PIPN). The present study …
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
Y Jiménez-Andrade, JL Flesher… - Hematology/Oncology …, 2024 - hemonc.theclinics.com
The advent of targeted molecular therapy and immunotherapy in clinical oncology heralded
explosive growth of data from the clinic that would shed new light on basic biology and …
explosive growth of data from the clinic that would shed new light on basic biology and …
Caracterização do papel das fibras sensitivas A (Trkb+) e fibras C (Neurotensina+) na dor nociceptiva e patológica
AGM Maganin - 2023 - teses.usp.br
A dor é compreendida como uma resposta gerada após o reconhecimento de um estímulo
nocivo, podendo estar associada à uma lesão real ou potencial. Porém, processos …
nocivo, podendo estar associada à uma lesão real ou potencial. Porém, processos …
Toripalimab Combined with Bevacizumab Plus Chemotherapy as First-Line Treatment for Refractory Recurrent or Metastatic Cervical Cancer: A Single-Arm, Open …
L Chen, S Liu, Y He, H Yao, Z Yuan, J Yang… - Open-Label, Phase II … - papers.ssrn.com
Background: Treatment strategies for refractory recurrent or metastatic cervical cancer (R/M
CC) are scarce. The synergistic antitumor effects of toripalimab plus standard therapy as first …
CC) are scarce. The synergistic antitumor effects of toripalimab plus standard therapy as first …